Pharma-Bio Serv, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Net Income (Loss) Attributable to Parent for the quarter ending July 31, 2024 was -$309K, a 159% decline year-over-year.
  • Pharma-Bio Serv, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending July 31, 2024 was -$841K, a 155% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $1.31M, a 30.1% increase from 2022.
  • Pharma-Bio Serv, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $1.01M.
  • Pharma-Bio Serv, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$2.09M, a 202% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$841K -$309K -$835K -159% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 -$5.44K -$214K -$618K -153% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $613K -$271K -$697K -163% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $1.31M -$47.1K -$221K -127% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $1.53M $526K +$238K +82.7% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 $1.29M $405K +$165K +68.6% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $1.13M $426K +$121K +39.7% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $1.01M $173K +$5.05M Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 -$4.04M $288K -$1.99M -87.3% May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q1 2022 -$2.05M $240K -$244 -0.1% Jan 31, 2022 Apr 30, 2022 10-Q 2022-06-14
Q4 2021 -$2.05M $305K +$37.2K +13.9% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 -$2.09M -$4.87M -$5.02M -3476% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 $2.93M $2.28M +$1.58M +229% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $1.34M $240K -$447K -65.1% Jan 31, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $1.79M $268K -$259K -49.1% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $2.05M $144K -$333K -69.8% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 $2.38M $692K +$261K +60.5% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $2.12M $688K -$19.9K -2.82% Feb 1, 2020 Apr 30, 2020 10-Q 2021-09-14
Q4 2019 $2.14M $527K +$55.9K +11.9% Nov 1, 2019 Jan 31, 2020 10-Q 2021-09-14
Q3 2019 $2.09M $478K -$2.86M -85.7% Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 $4.95M $431K -$299K -41% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $5.25M $707K +$836K Feb 1, 2019 Apr 30, 2019 10-Q 2020-09-14
Q4 2018 $4.41M $471K +$3.14M Nov 1, 2018 Jan 31, 2019 10-Q 2020-09-14
Q3 2018 $1.28M $3.34M +$3.89M Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 -$2.61M $731K +$894K May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 -$3.5M -$128K +$194K +60.2% Feb 1, 2018 Apr 30, 2018 10-Q 2019-09-16
Q4 2017 -$3.7M -$2.66M -$2.28M -597% Nov 1, 2017 Jan 31, 2018 10-Q 2019-09-16
Q3 2017 -$1.41M -$547K -$33.7K -6.57% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-29
Q2 2017 -$1.38M -$163K -$32.5K -24.9% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 -$1.35M -$323K -$360K -968% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
Q4 2016 -$989K -$382K -$732K -209% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$257K -$513K -$1.04M -198% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-29
Q2 2016 $780K -$130K -$584K -129% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 $1.36M $37.2K -$322K -89.6% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 $1.69M $350K +$61.6K +21.4% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 $1.62M $523K -$303K -36.7% Aug 1, 2015 Oct 31, 2015 10-K 2017-01-31
Q2 2015 $1.93M $454K -$143K -24% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 $2.07M $359K +$31.2K +9.53% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-14
Q4 2014 $2.04M $288K -$374K -56.4% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 $2.41M $827K -$393K -32.2% Aug 1, 2014 Oct 31, 2014 10-K 2016-01-29
Q2 2014 $2.81M $597K -$649K -52.1% May 1, 2014 Jul 31, 2014 10-Q 2015-09-14
Q1 2014 $3.46M $328K -$1.06M -76.4% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 $4.52M $662K -$391K -37.2% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $4.91M $1.22M +$143K +13.3% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 $4.76M $1.25M -$29.4K -2.3% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $4.79M $1.39M +$199K +16.8% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 $4.59M $1.05M -$93.3K -8.14% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $4.69M $1.08M +$252K +30.6% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 $4.43M $1.28M -$223K -14.9% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 $4.66M $1.19M +$708K +148% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 $3.95M $1.15M +$790K +222% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $3.16M $824K Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 $1.5M +$1.38M +1134% May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 $480K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 $356K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 $121K May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.